GlassScriptPhysician profile
Benjamin Perez-Ruiz
NPI 1548825201
$2,525.09
in general payments reported to CMS, 2019-2025
25 companies · $745 in 2025
The $745 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.72 · 2023: $700 · 2024: $1,065 · 2025: $745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,509.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $364.96 | 2023-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $323.30 | 2024-2025 | Gemtesa, Orgovyx |
| Endo USA, INC. | $140.54 | 2024-2025 | Xiaflex, Aveed |
| Gilead Sciences, INC. | $140.18 | 2023-2025 | Epclusa, Livdelzi |
| Urogen Pharma, INC. | $130.94 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $125.01 | 2024 | Breztri |
| Genzyme Corporation | $121.52 | 2024 | |
| Janssen Biotech, INC. | $114.25 | 2024-2025 | Erleada, Akeega |
| 180 Medical, INC. | $113.12 | 2024-2025 | |
| Abbott Laboratories | $110.72 | 2024 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $110.29 | 2023 | Uzedy |
| Edwards Lifesciences Corporation | $100.92 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Lilly USA, LLC | $99.02 | 2025 | Mounjaro |
| Alexion Pharmaceuticals, INC. | $98.44 | 2023 | |
| Mylan Specialty L.P. | $93.53 | 2023 | Yupelri |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $82.30 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Ethicon US, LLC | $56.44 | 2025 | Evarrest, Ethicon, Surgiflo Hemostatic Matrix |
| Abbvie INC. | $53.60 | 2024-2025 | |
| Boston Scientific Corporation | $33.27 | 2024-2025 | Rezum Generator, Axonics |
| Medtronic, INC. | $25.67 | 2025 | Signia |
| Axonics, INC. | $21.37 | 2024 | Axonics |
| Myriad Genetic Laboratories, INC. | $18.35 | 2024 | Prolaris |
| Heron Therapeutics, INC. | $16.99 | 2023 | Zynrelef |
| Janssen Pharmaceuticals, INC | $15.72 | 2022 | |
| Halozyme INC | $14.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Perez-Ruiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.